CAP	Controlled attenuation parameter
ESD	End-stage liver disease
CLD	Chronic liver disease
HCC	Hepatocellular carcinoma
WHO	World Health Organization
JAK	Janus kinase
EMT	Epithelial mesenchymal transition
COX-2	Cyclooxygenase-2
PGE2	Prostaglandin E synthase 2
EGFR	Epidermal growth factor receptor
PI3K	Phosphatidylinositol 3-kinase
AKT	Protein kinase B
AMPK	AMP-activated protein kinase
LDL	Low-density lipoprotein
PPAR γ	Peroxisome proliferator-activated receptor gamma
ACAT	Acyl-CoA: cholesterol acyltransferase
DNL	De novo lipogenesis
NAFLD	Nonalcoholic fatty liver disease
ChREBP	Carbohydrate response element binding protein
SREBP1c	Sterol regulatory element binding protein
FFA	Free fatty acid
PLGA	Polylactic-co-glycolic acid
CAPs	Controlled attenuation parameters
SLD	Steatotic liver disease
ASGPR	Asialoglycoprotein receptor
MRT	Mean residence time
MASH	Metabolic dysfunction-associated steatohepatitis
NF-κB	Nuclear factor kappa B
PBMC	Peripheral blood mononuclear cell
PLGA	Polylactide co-glycolide
α-SMA	α-smooth muscle actin
STAT3	Signal transducer and activator of transcription-3
TME	Tumor microenvironment
VEGF	Vascular endothelial growth factor
CAF	Cancer-associated fibroblasts
TACE	Transarterial chemoembolization therapy
CurDD	Curcumin diethyl disuccinate
CXCR4	C-X-C chemokine receptor type 4
MACs	Monocarbonyl analogs of curcumin
PLGA	Polylactic-co-glycolic acid
Gal-Mor-LPs	Galactose–morpholine modified liposomes
IONs@Cur	Curcumin-capped iron oxide nanoparticles
CCl4	Carbon tetrachloride
CeO2@SiO2	Cerium oxide-silica nanoparticles
CSLNs	Curcumin-loaded solid lipid nanoparticles
PAMAM-Gal	Polyamidoamine dendrimers anchored to galactosamine
DEN	Diethylnitrosamine
PAC	Pullulan acetate nanoparticles
C-SLNs	Curcumin-loaded solid lipid nanoparticles
aHSC	Activated hepatic stellate cells
IHC	Immunohistochemistry
ASGPR	Asialoglycoprotein receptor
MASLD	Metabolic dysfunction-associated steatotic liver disease
MASH	Metabolic dysfunction-associated steatohepatitis
ALD	Alcoholic liver disease